Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSEPT 1: Eptacog Beta in Hemophilia A or B with Inhibitors
NCT02020369Phase 3Completed
- Sponsor
- rEVO Biologics
- Start
- Apr 2014
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 3 trial of coagulation factor VIIa in hemophilia A, hemophilia B (HB), sponsored by rEVO Biologics. Started Apr 2014; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
hemophilia Ahemophilia B (HB)
Beyond the preview
Go deeper on NCT02020369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02020369.